However, the reported frequency of BRCA1/2 mutations in patients with high-grade serous carcinoma has been shown to vary between 19 and 30% [5, 6, 27, 29], which is in line with the results of our study (26.1%). Here, BRCA1 is linked to serous adenocarcinoma.